RAD51AP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.998200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.757800E-01
Normal-vs-Stage2
7.241800E-01
Normal-vs-Stage3
9.823600E-01
Normal-vs-Stage4
9.463600E-01
Stage1-vs-Stage2
3.324400E-01
Stage1-vs-Stage3
7.425800E-01
Stage1-vs-Stage4
7.092600E-01
Stage2-vs-Stage3
6.650800E-01
Stage2-vs-Stage4
6.411600E-01
Stage3-vs-Stage4
9.801800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.657600E-01
Normal-vs-AfricanAmerican
5.556600E-01
Normal-vs-Asian
8.550200E-01
Caucasian-vs-AfricanAmerican
7.378300E-02
Caucasian-vs-Asian
1.887010E-01
AfricanAmerican-vs-Asian
6.383200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.162200E-01
Normal-vs-Female
7.626200E-01
Male-vs-Female
9.241000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.434200E-01
Normal-vs-Age(41-60Yrs)
7.232800E-01
Normal-vs-Age(61-80Yrs)
8.413800E-01
Normal-vs-Age(81-100Yrs)
5.621800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.034800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.687000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.310600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.789800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.146800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.187400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.069000E-01
Normal-vs-Daily Drinker
8.542200E-01
Normal-vs-Weekly Drinker
7.654800E-01
Normal-vs-Occasional Drinker
6.505800E-01
Normal-vs-Social Drinker
7.388600E-01
Non Drinker-vs-Daily Drinker
1.978570E-01
Non Drinker-vs-Weekly Drinker
6.346800E-01
Non Drinker-vs-Occasional Drinker
7.884800E-01
Non Drinker-vs-Social Drinker
5.001600E-01
Daily Drinker-vs-Weekly Drinker
3.585000E-01
Daily Drinker-vs-Occasional Drinker
1.935580E-01
Daily Drinker-vs-Social Drinker
3.463800E-01
Weekly Drinker-vs-Occasional Drinker
7.979200E-01
Weekly Drinker-vs-Social Drinker
8.830400E-01
Occasional Drinker-vs-Social Drinker
6.493400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.999800E-01
Normal-vs-Grade 2
9.720400E-01
Normal-vs-Grade 3
8.171200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.067700E-02
Grade 1-vs-Grade 3
4.055700E-03
Grade 1-vs-Grade 4
7.999800E-01
Grade 2-vs-Grade 3
3.302800E-01
Grade 2-vs-Grade 4
9.720400E-01
Grade 3-vs-Grade 4
8.171200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.101400E-01
Normal-vs-NonDiabetic
7.944400E-01
Diabetic-vs-NonDiabetic
9.656000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.962400E-01
Normal-vs-NoPancreatitis
8.445400E-01
Pancreatitis-vs-NoPancreatitis
5.575600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.734600E-01
Normal-vs-N1
7.147400E-01
N0-vs-N1
7.900200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.249000E-01
Normal-vs-TP53-NonMutant
8.729600E-01
TP53-Mutant-vs-TP53-NonMutant
3.741500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
